Efficacy and Safety of Atrasentan in Patients With Cardiovascular Risk and Early Atherosclerosis

Endothelin plays an important role in the pathogenesis of atherosclerosis. The aim of the study was to evaluate the safety and hemodynamic and metabolic responses to 6 months treatment with atrasentan, the selective endothelin-A receptor antagonist. Seventy-two patients with multiple cardiovascular...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Raichlin, Eugenia, Prasad, Abhiram, Mathew, Verghese, Kent, Bailey, Holmes, David R., Pumper, Geralyn M., Nelson, Rebecca E., Lerman, Lilach O., Lerman, Amir
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2675066/
https://ncbi.nlm.nih.gov/pubmed/18695150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.108.113068
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller